The Serum Institute of India has sought emergency use authorisation from India's drug regulator for AstraZeneca Plc's Covid-19 vaccine, according to several reports in Indian media, citing Press Trust of India.

It applied to the Drugs Controller General of India, citing unmet medical needs due to the pandemic and in the interest of the public at large, the agency report said, citing official sources.